What orthopedic leaders have to say about weight loss drugs

Discover the potential impact of GLP-1 receptor agonists like Ozempic on the orthopedic industry as three surgeons share their insights on the drugs.

Related Keywords

San Francisco ,California ,United States ,John Prunskis ,Thomas Deberardino ,Ut Health San Antonio ,Illinois Pain Spine Institute Elgin ,Medicine Orthopedic Surgeon ,San Antonio ,Medical Director ,Illinois Pain ,Spine Institute ,Stone Clinic ,Glucagon Like Peptide 1 Receptor Agonists ,Ozempic ,Orthopedic Surgeons ,Potential Impact ,Field ,D ,Sports Medicine ,Glp 1 Receptor Agonists ,Disruptive Force ,Control ,Type 2 ,